| Literature DB >> 32545256 |
Farnoosh Pahlevanzadeh1,2, Rahmatollah Emadi1, Ali Valiani2, Mahshid Kharaziha1, S Ali Poursamar3, Hamid Reza Bakhsheshi-Rad4, Ahmad Fauzi Ismail5, Seeram RamaKrishna6, Filippo Berto7.
Abstract
Chitosan (CS) has gained particular attention in biomedical applications due to its biocompatibility, antibacterial feature, and biodegradability. Hence, many studies have focused on the manufacturing of CS films, scaffolds, particulate, and inks via different production methods. Nowadays, with the possibility of the precise adjustment of porosity size and shape, fiber size, suitable interconnectivity of pores, and creation of patient-specific constructs, 3D printing has overcome the limitations of many traditional manufacturing methods. Therefore, the fabrication of 3D printed CS scaffolds can lead to promising advances in tissue engineering and regenerative medicine. A review of additive manufacturing types, CS-based printed constructs, their usages as biomaterials, advantages, and drawbacks can open doors to optimize CS-based constructions for biomedical applications. The latest technological issues and upcoming capabilities of 3D printing with CS-based biopolymers for different applications are also discussed. This review article will act as a roadmap aiming to investigate chitosan as a new feedstock concerning various 3D printing approaches which may be employed in biomedical fields. In fact, the combination of 3D printing and CS-based biopolymers is extremely appealing particularly with regard to certain clinical purposes. Complications of 3D printing coupled with the challenges associated with materials should be recognized to help make this method feasible for wider clinical requirements. This strategy is currently gaining substantial attention in terms of several industrial biomedical products. In this review, the key 3D printing approaches along with revealing historical background are initially presented, and ultimately, the applications of different 3D printing techniques for fabricating chitosan constructs will be discussed. The recognition of essential complications and technical problems related to numerous 3D printing techniques and CS-based biopolymer choices according to clinical requirements is crucial. A comprehensive investigation will be required to encounter those challenges and to completely understand the possibilities of 3D printing in the foreseeable future.Entities:
Keywords: 3D printing; bio-inks; biomedical applications; chitosan; drug delivery; fabrication process; scaffolds; tissue engineering
Year: 2020 PMID: 32545256 PMCID: PMC7321644 DOI: 10.3390/ma13112663
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Suitable chitosan features for biomedical application.
Figure 23D printing methods historical background.
Figure 3Various applications of 3D printed chitosan constructs.
Figure 4Various types of printing methods (a) Stereo-lithography, (b) Powder Bed Fusion, (c) Binder Jetting, (d) Sheet Lamination, (e) Directed Energy Deposition, (f) Material Extrusion and (g) Material jetting [18,19,21].
3D printing methods and their raw materials, advantages and disadvantages.
| 3D Printing Method | Materials | Device Components | Manufacturing Process | Advantage | Disadvantage | Ref. |
|---|---|---|---|---|---|---|
| Stereolithography (SLA); Bottom-up SLA; Top-down SLA | A resin with photo-active monomers | Laser, Vat of resin, UV light, Platform | The SLA technique is classified to top-down and bottom-up (based on build platform movement and laser motion). The laser is utilized for initiating photopolymerization and converting liquid resin to solid shape via photocuring process. | Various applications, Printing living tissues, Having the highest resolution among other printing methods, SLA has the ability of making structures with a resolution of 20 μm or less, which is the highest resolution among other printing methods (with resolution of 50-200 μm) | Lack of monolithic mechanical structure due to layer by layer fabrication process. Time consuming process caused by low photopoly-merization rates | [ |
| PBF (SLS, SLM, 3DP) | Metals and alloys, Limited polymers, Ceramic | Laser, Powder roller, Powder bed, Powder stock, Platform | The working method is to spray powder materials on the previous layers and laser is utilized for fusing powders together. | Good resolution, High quality | Slow printing rate, Expensive process, High porosity | [ |
| Binder Jetting or indirect 3D printing | Metals, Polymers, Ceramics | Powder roller, Powder stock, Build Platform, Powder bed, Binder cartridge, and inkjet print head. | The binder jetting techniques is used for powders and powder layers binds together with adhesive. The powder is sprayed on the platform via roller. The head of print sprinkled the adhesive on top of the powder according to the structure designed by the computer. The platform comes down by the thickness of object’s layer. Next layer is made by spraying powder on the previous layer. The object is fabricated via powder and the liquid bounding. | Ceramics has more challenges to use by additive manufacturing than polymers and metals technologies due to high melting temperature; Hence, binder jetting can be a promising method to fabricate ceramic based materials. Cost effective, No shrinkage | Low mechanical properties | [ |
| Sheet Lamination | Metals (aluminum, copper, stainless steel and titanium), Ceramic, and Composite | Laser, Platform, Mirror, Material spool, Cross hatched material, Support material, | UAM and LOM are two strategies of sheet lamination. The material is placed on platform and bonded to the previous layer by the adhesive materials. The designed structure is cut from the layer via laser. Then next layer is made. | Low shrinkage and residual stresses, Quick process | Difficulty of precision in the Z-dimension control, Lack of mechanical homogeneity in products because of utilizing adhesive in fabrication process | [ |
| Directed Energy Deposition | A resin with photo-active monomers, Hybrid polymer-ceramics, Metals and alloys in the form of powder or wire, Ceramics and polymers | Electron beam, Metal Wire supply, Metal wire, Platform | The powder or wire is placed in the pool of melt which is glued to a lower part or layers via source of energy (laser or electron beam). | Cost effective and quick process, Favorable mechanical properties, Control on microstructure | Low accuracy and surface quality, Restrictions on printing complex geometric shapes with precise details | [ |
| Material extrusion FDM and FFF | Plastics, Polymers | Material spool, Heater element, Nozzle, Heater element | Thermoplastic materials are melted and extruded and create layers by moving the nozzle according to the computer design. | Ease of use, Suitable mechanical properties | Filament required, Restriction of raw materials, Inability to print live cells | [ |
| Material jetting | Plastics, Polymers | UV light, Elevator, Platform, | The MJM mechanism of action is similar to ink jet printer. Material jetting on platform is done (drop or continuous) | High accuracy, Low waste of material | Restriction of raw materials: polymers and waxes, Required support material | [ |
Figure 5Schematic representation of the preparation process of the scaffolds [86].
Figure 6Soft tissue application of printed chitosan based constructs, (a) Schematic representation of hNSCc-laden AL-CMC-Ag bioink printing for nerve regeneration application, (b) Chitosan-gelatin preparation and cross-link process, (c) CS and PEC interactions to achieve wound dressing with a capacity of lidocaine delivery and (d) Starfish and leaf printed using chitosan ink referring to printability of chitosan ink at room temperature [121,123,138,155].
The utilized material, method and physical, mechanical and cellular characterizations in 3D printed chitosan based construct.
| Biobased-Material | 3D Printing Method | Solvent | Printed Structure | Porosity, Pore Size | Mechanical Properties | Cellular Assay | Cell Type | Target Tissue | Ref |
|---|---|---|---|---|---|---|---|---|---|
| CS, PCL-DA and PEG-DA | RDMAM system | Benzene, acetone and acetic acid. | Multi-layer scaffolds | Pore size = 300 μm | PCL-DA/PEG-DA/CS 5% tensile strength = 0.75 ± 0.05, | Well cell viability and proliferation | L929 cells | TE | [ |
| CS (6% w/v) and CS modified with raffinose | FDM | 2% acetic acid | 3D scaffolds | Feret diameter: scaffold without raffinose 10 ± 20 μm; scaffold with raffinose 3.5 ± 3 μm | - | Well cell adhesion and proliferation | Fibroblasts | Soft tissue engineering | [ |
| PLA, CS and Maleic anhydride-grafted PLA (PLA-g-MA) | An extruder (by heating and melting) | - | (3D) printing strips | - | Tensile strength of PLA-g-MA/CS (20 wt%) ≈ 52 | Well cell viability | Human foreskin fibroblasts | Biomedical material | [ |
| CS, Gel and HA | FDM | 2% acetic acid | 3D scaffolds | Pore size ≈ 200–500 µm | - | Well cell viability and proliferation | MC3T3-E1 cells | BTE | [ |
| AL, AL-HA, CS, CS-HA | The Fab@Home™ (The Seraph Robotics) open source RP platform Model | PBS, 0.1 M acetic acid | Scaffolds with disc shape (6 mm diameter × 1 mm thickness) | Average pore size of pure CS ≈ 200 μm and CS-HA ≈ 100 μm | - | Well cell viability, proliferation and osteogenic differentiation | MC3T3-E1 pre-osteoblast | BTE | [ |
| CS, HA | Z-Corp, Z-510 Solvent/dispensing | Lactic acid, citric acid, acetic acid | 3D scaffolds | Porosity = 37.1% | Compressive strength = 16.32 ± 2.8 MPa | - | - | BTE | [ |
| CS, calcium phosphate | Robocasting | Acetic acid | 3D scaffolds | Porosity = 22% | - | - | - | Filler for large bone defects | [ |
| PCL, CS | FDM | 0.1 M acetic acid | 3D scaffolds | PCL/CS porosity = 62.4 ± 0.23% | Compressive strength ≈ 6.7 MPa | Well Cell viability, Proliferation and expressions of Osteogenic gene | Rabbit BMMSCs | BTE | [ |
| PLLA, CS and bioactive Qu, PDA | 3D printer (MakerBot Replicator Z18) via a FDM) | 0.1% (v/v) acetic acid aqueous solution | Cylindrical scaffolds | - | Compressive strength of PLLA/CS-D/Qu ≈ 15 MPa and elastic modulus ≈ 0.140 GPa (dry condition) | Well cell attachment, osteogenic activity and good anti-inflammatory feature | MC3T3-E1 cell | BTE | [ |
| CS, PVA and various ratio of HA (2.5, 5, 10, and 15 wt %) | Pushing of Hydrogel from the syringe (by computer controlling) and spraying the crosslinking agent | Acetic acid, distilled water | 3D scaffolds | Pore size = 800 to 1300 μm | Elastic modulus of CS/PVA containing 15 wt% HA ≈ 91.14 MPa | Well cell viability and adhesion | hMSCs | BTE | [ |
| MAG-Lp, MAC-Lp | Robocast-assisted deposition system | Acetic acid | 3D scaffolds | Average pore size = 389 ± 58 µm based on horizontal, 385 ± 38 µm based on vertical for MAC-Lp. | Compressive strength ≈ 14–15 MPa for MAC-Lp | Enhanced osteoblast growth and biomineral formation | MC3T3-E1 | Osteoblast growth | [ |
| PLA, CS and HA | FDM | 0.36% of acetic acid | 3D scaffolds | Very large pore diameter ≈ 960 ± 50 mm, Porosity ≈ 60% | PLA/CS-HA modulus = 16.4 ± 2.5 MPa | Well cell viability and osteogenic differentiation | hMSCs | BTE | [ |
| CS, HA | Robotic dispensing System Solvent/dispensing | Acetic acid/NaOH ethanol | 3D scaffolds | Macropore = 400–1000 µm for CS scaffolds, macropore size = 200–400 µm for the CS–HA scaffolds | - | Well cell adhesion and distribution | Osteoblasts | BTE | [ |
| CS, nBA | Robocasting | Acetic acid | 3D scaffolds | Macro structure (hundreds of micrometers) and highly micro-pore = a few to 10 μm | - | Well cell adhesion and spread | MC3T3-E1 preosteoblastic cells | BTE | [ |
| CS scaffolds + IPFP-ASCs + TGFb3 and BMP6 | Extrusion printed onto a glass slide, immersion in bath of isopropyl alcohol. | Acetic acid | Scaffolds | - | - | A shiny cartilage-like tissue ‘cap’, positive staining of collagen I, II and cartilage proteoglycans | IPFP-ASCs | Osteochondral graft | [ |
| Resin, CS and PEGDA | Stereolithography | 1% acetic acid | 3D printed ear scaffold | Pore size ≈ 50 µm | Elastic modulus ≈ 400 kPa | Long term cell viability and spreading | hMSCs | Complex tissue geometries, such as human ear | [ |
| CS, AL | Uprint, Z402 | Acetic acid | 3D scaffolds | Pore size ≈ 100 μm pores | - | Improvement of cell suspension uptake | Mouse bone marrow stromal cells | CTE | [ |
| Col, CS | A 3D bioprinter | 1% acetic acid | 3D scaffolds | Porosity = 83.5% pore size 60–200 μm | Compressive | Implementing | NSCs were obtained from embryonic brains at day 14 | SCI | [ |
| strength of 3D-Col/CS = 345.20, 29.60 KPa and Compressive modulus = 3.82 ± 0.25 MPa | 3D-C/C scaffold enhanced the number of biotin dextran amine fibers and led to smaller cavity and a more linear-ordered structure | ||||||||
| CS-g-oligo (L,L-lactide) copolymer and PEGDA as a cross linker | Two-photon-induced micro stereolithography | 3 vol.% acetic acid | A truncated cylinder scaffolds | - | - | A high survival rate of cortical neurons and the formation of neural networks | Dissociated rat cortical neurons | NTE | [ |
| CS, laminin | DBRP | Acetic acid | 3D nerve conduit scaffolds | - | - | Laminin improves the viability of neurons grown and the length of neurite growth | Adult DRG neurons | NTE | [ |
| Al, CMC and agarose | Direct write printing (Extrusion-based-3DBioplotter System) | PBS | 3D scaffolds | - | - | Well hNSC expansion and differentiation | hNSC | NTE | [ |
| CS, GE as a cross linker, GLY and PEG as plasticizer | A 3D printer with jet dispenser | 0.5% v/v acetic acid | Film | - | - | Well cell viability | Human skin fibroblast cell | Chronic wound healing | [ |
| CS, PEC | Extrusion-based 3D printing | 0.1M HCl | A mesh scaffold model | - | Self-adhesion to skin with bioadhesion strength in the range of 86.5–126.9 g | - | - | Wound healing, local LDC release | [ |
| Polyelectrolyte Gel, CS | A 3D bioprinter, (extrusion-based print-head) | Acetic acid, PBS solution | A 3-layered grid-like patterns | - | - | Well cell viability and proliferation, spindle-like morphology | Fibroblast skin cells (HFF-1) | STE | [ |
| Polyelectrolyte CS, Gel | A 3D bioprinter, Biofactory | CS in acetic acid, gelatin in PBS | Multi-layered hydrogel construct | - | - | Well cell viability and proliferation, spindle-like morphology, | Naonatal human foreskin fibroblasts (HFF-1) | STE | [ |
| CS | FDM | Acetic acid 2% (v/v) containing D-(+) raffinose pentahydrate | 3D scaffolds with grid of orthogonal filament | Pore size ranges = from 4 to 9 μm | - | An early skin-like layer consisting of fibroblast and keratinocyte | Human fibroblast (Nhdf) and keratinocyte (HaCaT) | STE | [ |
| PCL, CS | Materials extrusion, (by melting materials) | - | Vessel-like scaffolds | - | Elastic modulus for PCL/7 wt%CS/5 wt%H = 174 MPa | Well cell viability and growth | HUVEC cell | Cardiovascular diseases | [ |
| Al, CS | A single arm robotic printing | Deionized water, 1.0 M acetic acid | Channels in form of hollow tubes | - | Maximum tensile stress = 5.65 ± 1.78 kPa and Young’s modulus = 5.91 ± 1.12 kPa | Well cell viability | CPCs | Vascular networks | [ |
| CS and Gel hybrid, glutaraldehyde as a cross linker | Combining rapid prototyping, microreplication and freeze–drying | 1 wt% acetic acid | 3D scaffolds | Porosity = 90–95%, pore size = 100 µm | Compressive strength ≈ 264 ± 10.1 KPa | Well hepatocyte attachment and viability ≈ a bove 90% Well albumin secretion and urea synthesis | Hepatocytes | HTE | [ |
| Col, CS | A bioprinter with two syringes | 0.10 M acetic acid | Meshes design | Square holes of 4 mm on each side | - | No cell morphology change, Non-cellular toxicity | NIH/3T3 fibroblasts monolayers | TE | [ |
| CS | Extrusion-based 3D printing | Acidic mixture (40 vol% acetic acid, 20 vol% lactic acid, 40 vol% distilledwater | 30-layer scaffolds, starfish, leaf, and spider shapes | Pore size ≈ 220 µm | Maximum tensile strength ≈ 97 MPa (dry condition) and high strain at break ~360% in the wet condition | - | - | Inks for 3D Printing, tissue engineering, drug delivery | [ |
| BMSCs-laden Gel, sodium alginate and CMC | Micro extrusion-based 3D printer equipped with z-axis-controlled ink reservoirs | water | 3D scaffolds | - | Young modulus ≈ 120 MPa | Well cell viability | BMSCs | TE | [ |
| CS | Direct printing of chitosan ink in air (Extrusion-based method) and partial hardening via solvent evaporation | Acidic mixture: 40 vol% acetic acid, 10 vol% lactic acid, and 3 wt% citric acid). | 3D scaffolds | Microfiber networks, pore size ≈ 220 μm | Tensile strength ≈ 7.5 MPa | Well cell Survival and proliferation | L929 fibroblasts | Biomedical materialS | [ |
AL: Alginate; BTE: Bone tissue engineering; BMSCs: Bone mesenchymal stem cells; BMP-2: Bone morphogenetic protein-2; CS: Chitosan; CMC: Carboxy methyl chitosan; CPCs: Cartilage progenitor cells; CTE: Cartilage tissue engineering; Col: Collagen; DBRP: Dispensing-based rapid prototyping; DRG: Dorsal root ganglion; FDM: Fuse deposition manufacturing; GE: genipin; Gel: Gelatin, GLY: Glycerol; HA: Hydroxyapatite; hMSCs: Human mesenchymal stem cells; hNSC: Human neural stem cells; IPFP-ASCs: Infrapatellar fat pad adipose stem cells; MAC-Lp: methacrylated chitosan-laponite; MAG-Lp: methacrylated gelatin-laponite; nBA: Nano bioactive glass; NVE: Nerve tissue engineering; NSCs: Neural stem cells; PBS: Phosphate buffer saline; PCL-DA: poly (ϵ-caprolactone) diacrylate; PDA: polydopamine; PEC: Pectin; PEG: Poly ethylene glycol; PEGDA: Polyethylene glycol diacrylate; PLA: Poly (lactide acid); PLLA: poly (L-lactide); PVA: poly (vinyl alcohol); Qu: quercetin; RDMAM: Reflective dynamic mask additive manufacturing; RP: Rapid prototyping; SCI: Spinal cord injury.
Figure 7Challenges and solutions to overcome for chitosan 3D printed constructs.